Igor Mokrousov

Plain English
This study looked at the complete genetic makeup of two types of tuberculosis bacteria: the older strain and a newer strain linked to more severe illness. The researchers found that the modern strain has a higher ability to cause serious disease. This is important because understanding these genetic differences can help in developing better treatments and prevention strategies for tuberculosis. Who this helps: This benefits patients with tuberculosis and health care providers working to treat them.

Plain English
This study looked at the issue of antimicrobial resistance (AMR) in the Southeast Asia and Western Pacific regions, where more than half of the world's population resides. It found that although there are many political commitments to address AMR, there is a significant gap between these promises and actual actions taken, leading to ineffective governance. The researchers recommend a new approach to improve this situation by using implementation science—a method for turning research into practical actions—which could lead to effective strategies for managing AMR in these areas. Who this helps: This helps patients, healthcare providers, and public health officials in regions dealing with antimicrobial resistance.

Plain English
Researchers studied the spread of multidrug-resistant tuberculosis (MDR-TB) in the Arkhangelsk region of northern Russia, finding that the prevalence of specific strains known as Beijing strains increased significantly from 39.3% in 1998 to 67.0% by 2018. They found that all Beijing B0/W148 strains were MDR, and the proportion of this specific strain also nearly doubled from 11.2% to 20.5% during the same period. These findings show that these Beijing strains play a crucial role in spreading drug-resistant TB in the area, making ongoing monitoring very important. Who this helps: This research benefits public health officials and healthcare providers in managing and controlling TB outbreaks.

Plain English
The study looked at new anti-tuberculosis drugs called aroylhydrazones and nitrofuroylamides to find out how they affect bacteria that are resistant to existing treatments. Researchers found that these new compounds led to several significant genetic mutations in the bacteria; for example, some mutations were linked to drug tolerance and the ability to survive stress. Understanding these mutations helps develop better treatments for drug-resistant tuberculosis. Who this helps: This helps patients with drug-resistant tuberculosis.

Plain English
This study looked at the different types of bacteria found in the necrotic tissue of tuberculosis (TB) lesions. Researchers found that in some cases, up to 99.9% of the bacteria in this tissue were the TB-causing bacteria Mycobacterium tuberculosis, while in other cases, there was a mix of bacteria, with other types being more common. Understanding these bacterial communities is important because it can help in developing better treatments for TB and managing drug resistance. Who this helps: This helps patients with tuberculosis.

Plain English
This study looked at how the bacteria that cause tuberculosis (Mycobacterium tuberculosis) reacted to a new drug compound. Researchers found that the compound effectively inhibited the bacteria at a low concentration of 0.4412 µM but identified a resistant strain that could survive at much higher levels. A specific mutation in the Rv3755c gene was linked to this resistance, suggesting that understanding this mutation may lead to better strategies for dealing with drug-resistant tuberculosis. Who this helps: This helps doctors and researchers working on tuberculosis treatment.

Plain English
This study looked at how human respiratory syncytial virus (HRSV), a major cause of respiratory infections in kids, changed over six years in central China. Researchers found that HRSV infections dropped significantly during strict COVID-19 measures, with rates going from 16.34% in 2021 to just 3.27% in 2022. However, after these restrictions were lifted in 2023, infections surged to 21.47%, especially among infants under a year old, who were nine times more likely to be infected compared to older children. This highlights the need for ongoing virus monitoring as the pandemic changes, to better protect children’s health. Who this helps: Parents and healthcare providers caring for young children.

Plain English
This study looked at how the COVID-19 pandemic affected tuberculosis (TB) patients in Siberia and the Far East of Russia. Researchers found that more than 80% of TB strains were of the Beijing genotype, which includes different clusters; during the pandemic, a specific cluster less likely to resist treatment became more common, resulting in an increase in treatment effectiveness for patients also infected with COVID-19. In contrast, treatment effectiveness dropped by over 20% for TB patients without COVID-19 due to the prevalence of a more drug-resistant strain. Who this helps: This benefits TB and COVID-19 patients by improving our understanding of how these diseases interact and affect treatment outcomes.

Plain English
This study examined how different strains of Mycobacterium tuberculosis affect kidney health in rabbits with renal tuberculosis. It found that a more virulent strain (H37Rv) caused significant changes in certain blood proteins and less severe damage to kidney structures compared to a less virulent, multidrug-resistant strain (5582); specifically, after 22 weeks, the virulent strain led to higher levels of certain enzymes (like MMP-9) but less overall kidney tissue damage than the other strain. Understanding these differences helps pinpoint the varying impacts of tuberculosis strains on kidney health, which is crucial for developing targeted treatments. Who this helps: Patients with renal tuberculosis and their healthcare providers.

Plain English
This study focused on improving the detection of a specific type of tuberculosis bacteria called the Haarlem genotype. Researchers created a new testing method, using real-time PCR, that accurately identified this genotype in a diverse group of bacteria samples. They found that out of 428 samples, 396 were correctly identified, and they discovered more Haarlem cases than expected, highlighting the need for better monitoring of this strain. Who this helps: This research benefits doctors and health officials who are working to track and control tuberculosis outbreaks.

Plain English
This study looked at how effective new chemotherapy drugs are against different strains of drug-resistant tuberculosis (TB) bacteria in mice. The researchers found that while treatment helped reduce lung damage and inflammation overall, some strains caused more serious illness than others: the highly virulent Beijing 396 strain resulted in the most lung damage, while the less harmful Beijing 6691 and LAM 7074 strains were easier to treat. Interestingly, after nearly six months of treatment, the bacterial load in the lungs of most treated mice increased slightly, highlighting the challenges in fully clearing the infection. Who this helps: This research assists doctors and researchers in developing better treatment strategies for patients with drug-resistant TB.

Plain English
This study looked at the Haarlem strain of tuberculosis (TB) to understand where it came from and how it spread. The research found that this strain is most common in Central Europe, making up 33-41% of TB cases in countries like Czechia, Austria, and Hungary, but it decreases to 10-18% in places like Italy and France. Understanding the spread of this strain is important because it helps track how TB spreads through human migration, especially in specific ethnic groups. Who this helps: This benefits public health officials and researchers working to control and prevent tuberculosis outbreaks.

Plain English
Researchers studied a group of bacteria known as the complex (MKC) that can cause serious diseases similar to tuberculosis. They analyzed 665 strains of these bacteria from humans, animals, and the environment and found that they share some genetic features but also have unique differences. Notably, one lineage of these bacteria is widespread worldwide, while others are mostly found in Brazil, and they discovered close to 300 genetic variations that may be tied to higher virulence and resistance to treatment. Who this helps: This benefits patients at risk for serious infections, especially those caused by antibiotic-resistant bacteria.

Plain English
This study looked at how different strains of tuberculosis (TB) affect the lungs and how the body's immune response reacts to these strains. Researchers found that mice infected with the highly lethal "Buryat" strain of TB had a strong immune response and higher levels of certain markers like iNOS and TNF, indicating greater lung damage compared to those infected with the less dangerous "Omsk" strain, which showed a weaker immune response and lower marker levels. Understanding these differences is important as it can help in developing targeted treatments and managing TB infections better. Who this helps: This helps doctors and researchers in treating TB patients more effectively.

Plain English
This study looked at the increasing cases of nontuberculous mycobacteria (NTM) infections in Bulgaria from 2018 to 2022, finding a variety of species, some common and some rare, that were previously undetected by standard tests. They identified a new species, sp. nov, and noted significant changes in NTM types due to environmental and demographic factors. This research is important because it helps improve how these infections are diagnosed and treated, which can lead to better health outcomes. Who this helps: This benefits patients with NTM infections and healthcare providers aiming for accurate diagnosis and effective treatment.

Plain English
This study examined the effectiveness of essential oils from four Bulgarian roses against different strains of tuberculosis bacteria. The researchers found that one type of rose oil was particularly effective, inhibiting growth at very low concentrations (0.16-0.31 mg/mL), while another was much less effective (0.62-1.25 mg/mL). Understanding how these oils work could lead to new treatments for tuberculosis, especially since some strains are resistant to current antibiotics. Who this helps: Patients with tuberculosis, especially those with drug-resistant strains.

Plain English
This study examined strains of multi-drug resistant tuberculosis (MDR-TB) in Buryatia, a diverse region in the Russian Far East. Researchers found that 68% of strains from Russian patients were of the Beijing type, while 39.2% of strains from Buryat patients were non-Beijing types, showing significant differences in strain types between the two ethnic groups. This is important because the presence of highly resistant strains increases the risk of spreading TB in the community, which can complicate treatment efforts. Who this helps: This information benefits healthcare providers and public health officials working to control TB in ethnically diverse populations.

Plain English
This study looked at drug-resistant strains of tuberculosis (TB) bacteria found in Plateau State, Nigeria. Researchers identified specific genetic changes in the bacteria that make them resistant to common TB treatments. Understanding these changes is crucial for developing better therapies and tackling TB effectively. Who this helps: This helps patients battling tuberculosis, especially those with drug-resistant infections.

Plain English
This study examined the genetic differences of certain mini DNA sequences, called VNTR loci, in cattle from various farms in Bulgaria. Researchers looked at 43 samples collected between 2015 and 2021 and found that cattle from different areas showed notable genetic variation, with a higher diversity among those spread over a larger geographical area (67% vs. 60%). This information is important because it can help in tracking and monitoring bovine tuberculosis (bTB) in Bulgaria by identifying key genetic markers for testing. Who this helps: This benefits farmers and veterinarians managing cattle health, particularly in controlling bTB outbreaks.

Plain English
This study focused on tuberculosis (TB) in the Omsk region of Western Siberia, where the rates of TB infection have decreased, but multidrug-resistant TB (MDR-TB) cases have increased. In 2021, 851 newly diagnosed patients showed that the rate of MDR-TB rose from 19.2% in 2012 to 26.4%. This is important because more than half of the tested TB strains were drug-resistant, making it harder to treat and manage the disease, especially since 19.2% of these strains were extremely drug-resistant (XDR). Who this helps: This information benefits healthcare providers and public health officials working to control TB and protect patients at risk.

Plain English
This study looked at the genetic types of tuberculosis (TB) bacteria found in Poland between 2018 and 2021, comparing multidrug-resistant (MDR) cases with drug-sensitive (DS) ones. Out of 89 samples, the researchers found that 28% belonged to the Beijing family of bacteria, with 61.5% of MDR cases being of this type, while only 2% of DS cases were. This is important because it shows that the Beijing strain is spreading more among people with drug-resistant TB, especially among those born outside Poland, which may be linked to imported cases from surrounding countries. Who this helps: This research helps public health officials and doctors by providing crucial information on TB strains to better manage and treat the disease.

Plain English
This study examined old human bones from cemeteries in Irkutsk, Eastern Siberia, to find evidence of tuberculosis infections from the 18th and 19th centuries. The researchers analyzed 591 skeletons and found that four tested positive for tuberculosis DNA, all of whom were men from between the 18th and 19th centuries. This finding is important because it shows that different strains of tuberculosis were present in this area, indicating a mix of European and local origins for the disease. Who this helps: This helps researchers and public health officials understand the historical spread of tuberculosis, which can inform current prevention and treatment efforts.

Plain English
This study looked at drug resistance patterns in tuberculosis (TB) strains affecting children in China and Russia, where the disease is particularly severe. Researchers analyzed samples from 137 children in China and 60 in Russia and found that 68% of the Russian strains were multi-drug resistant, while no specific resistance patterns were linked to Chinese strains. Understanding these patterns is crucial for improving treatment strategies and controlling the spread of resistant TB. Who this helps: This helps patients and healthcare providers dealing with pediatric tuberculosis.

Plain English
This study focused on different strains of a type of tuberculosis known as Latin-American-Mediterranean (LAM) to understand their behavior and how they respond to treatment. Researchers found that a highly virulent strain that is sensitive to drugs has become more common, while a previously concerning multidrug-resistant strain has almost disappeared. This is important because it shows that the characteristics of these strains can change over time, highlighting the need for careful monitoring and tailored treatment strategies for tuberculosis. Who this helps: This benefits patients and doctors by informing better treatment options and monitoring strategies for tuberculosis.

Plain English
This study looked at the different types of a specific strain of tuberculosis (TB) found in Northwestern Russia and how resistant these strains are to treatment. Researchers found that the Beijing genotype accounted for 57.5% of the 497 TB cases tested, with half of these strains being multidrug-resistant (MDR). The B0/W148 strains were particularly concerning, showing an MDR rate of 85.7%, which highlights a significant public health threat since this resistance makes TB more difficult to treat. Who this helps: This research benefits patients with tuberculosis and healthcare providers working to treat and control the disease.

Plain English
This study focused on a highly dangerous strain of tuberculosis (TB) called the Mycobacterium tuberculosis Beijing 14717-15-cluster, found mostly in Far Eastern Russia. Researchers discovered that this strain is multidrug-resistant and very lethal, with common mutations that may increase its ability to cause disease. Specifically, the research identified over 115 genetic changes that distinguish this strain and developed a new test to quickly identify it in patients. Who this helps: This helps doctors and public health officials track and treat dangerous TB strains more effectively.

Plain English
This study examined the spread of drug-resistant tuberculosis (TB) in Mongolia and Eastern Siberia (Russia) by analyzing samples from both regions. Researchers found that the Beijing strain of TB was the most common, making up 75% of cases in Mongolia and 69% in Russia, but the rates of multidrug-resistant TB were significantly higher in Russia (29.4%) compared to Mongolia (5.6%). Understanding these differences is important for developing effective TB control strategies in these areas. Who this helps: This research benefits public health officials and TB patients in Mongolia and Russia.

Plain English
This study looked at the genetic makeup of bacteria called Mycobacterium bovis and M. caprae found in cattle in Bulgaria between 2015 and 2020. Researchers analyzed 37 samples and discovered they belong to three main genetic groups, with 34 samples showing distinct genetic differences, indicating limited spread of the disease in Bulgaria. The results suggest that while there's some diversity in the bacteria, active transmission in cattle seems low, although dormant strains may still exist. Who this helps: This benefits veterinarians and cattle farmers by providing insights into the spread of bovine tuberculosis in their herds.

Plain English
This study looked at drug-resistant strains of tuberculosis (TB) from patients in Plateau State, Nigeria. Researchers tested 67 samples and found that most (91%) belonged to two major lineages, Cameroon and T. The results help us understand how TB spreads in this region and highlight the need for targeted strategies to combat the disease, especially since Nigeria has high rates of TB. Who this helps: This benefits patients and public health officials working to control TB.

Plain English
This study looked at the strains of the bacteria causing tuberculosis (TB) in Western Siberia before and during the Covid-19 pandemic. Researchers analyzed 269 samples and found that most were from the "Beijing" type of TB, which is often resistant to treatment (Multidrug-Resistant or MDR). They noticed a slight decrease in the Beijing type and a rise in other strains during the pandemic, but the overall issue of MDR TB remains serious, with 80% of pre-pandemic samples and 68% during the pandemic being resistant to multiple drugs. Who this helps: This information is crucial for healthcare providers and public health officials working to control TB outbreaks and improving treatment strategies.

Plain English
This study focused on a new type of drug called nitrofuranyl amides, which targets tuberculosis (TB). Researchers tested the anti-TB activity of these drugs by observing how certain bacteria developed resistance after exposure to them. They found that as the drug concentration increased, bacteria showed a significant rise in genetic mutations related to resistance, specifically identifying six mutations in key genes. This matters because understanding how bacteria become resistant can help in designing more effective treatments for TB. Who this helps: Patients with tuberculosis and healthcare providers managing their treatment.

Plain English
This study examined different strains of the bacteria that cause tuberculosis (TB) in patients from Omsk, Russia, focusing on how their characteristics affect the disease's severity and death rates. Among the 548 patients tested, the Beijing strain was found in 67.5%, with the hypervirulent 14717-15 strain linked to a 58.3% death rate, significantly higher than the 31.4% for another strain and 15.2% for non-Beijing strains. This research shows that both the drug resistance and the virulence of TB strains are important when tailoring treatment plans for patients. Who this helps: This helps doctors and healthcare providers as they develop personalized TB treatments for patients.

Plain English
This study focused on a specific strain of tuberculosis (TB) called the Beijing A strain, which is particularly prevalent in Colon, Panama, an area with a high rate of TB. Out of 42 samples examined, 17 (40.5%) were found to be the Beijing A strain, and later surveillance confirmed that this strain made up 44.1% of cases from September 2019 to March 2020. The findings indicate that this strain has been around for a while and is not mainly due to recent infections, which is important for controlling its spread and treating patients effectively. Who this helps: This helps patients in Colon and healthcare providers working to manage tuberculosis in the region.

Plain English
This study looked at a specific type of tuberculosis bacteria called SIT53 and how it relates to other types within the broader Mycobacterium tuberculosis family. Researchers analyzed 266 samples from different parts of the world and found that SIT53 does not belong to any specific family but instead has subpopulations that have evolved separately, indicating a complex and varied relationship among these bacteria. These findings matter because they highlight the diversity within tuberculosis, which can impact how we understand and treat infections. Who this helps: This benefits researchers and public health officials working on tuberculosis treatment and prevention.

Plain English
This study focused on the genetics of Mycobacterium tuberculosis complex (MTBC), a group of bacteria responsible for tuberculosis. Researchers analyzed the genetic differences across 721 samples and confirmed 79 specific regions in the bacteria's DNA, 17 of which were newly identified. These findings provide valuable insights into how different strains of the bacteria evolve and can improve methods for diagnosing and studying tuberculosis. Who this helps: This research benefits doctors and scientists working to understand and treat tuberculosis.

Plain English
This study examined how drug-resistant tuberculosis (TB) is spreading in Estonia, a country with a high priority for TB control. Researchers analyzed 278 TB samples taken between 1999 and 2015. They found that the most common type of TB, known as the Beijing genotype, increased from 28.6% to 38.5%, and the number of samples resistant to multiple drugs rose from 22.4% to 29.1%. This is important because it highlights growing challenges for controlling TB, especially among patients with HIV or alcohol abuse issues, which complicates treatment and increases health risks. Who this helps: This helps patients and healthcare providers by highlighting the need for better TB control strategies in high-risk populations.

Plain English
This research focused on two dangerous strains of tuberculosis bacteria found in Eastern Russia. The study revealed that one strain (from Buryatia) caused higher mortality rates in mice, leading to 100% death in tested groups, while the other strain (from Omsk) was less harmful. These findings are important because they highlight the emergence of particularly lethal strains of tuberculosis that are resistant to multiple drugs, which could pose a significant threat to public health in the region. Who this helps: This information benefits public health officials and doctors dealing with tuberculosis in affected areas.

Plain English
This research focused on a specific group of drug-resistant tuberculosis bacteria known as the Beijing 1071-32 cluster, which is mostly found in Siberia, Russia. Researchers discovered that this strain is highly resistant to many treatments and identified three specific genetic markers that can be tested for using a new diagnostic tool. This is important because it allows for better tracking and detection of these dangerous bacteria, helping to control their spread. Who this helps: This helps patients at risk of drug-resistant tuberculosis and healthcare providers monitoring outbreaks.

Plain English
This study looked at tuberculosis (TB) bacteria in Albania, analyzing samples from 743 cases collected between 2007 and 2011. The researchers found that most of the TB strains belonged to a category called "Lineage 4," which includes local and some European types, while a smaller portion had some drug resistance—60% of the Beijing strains and 13.9% of unclassified Lineage 4 strains were resistant to treatment. These findings matter because they provide insights into the TB strain diversity in Albania and suggest that drug resistance is still relatively low, which is important for public health. Who this helps: This information benefits public health officials and clinicians treating TB patients in Albania.

Plain English
The study examined a specific group of tuberculosis bacteria known as the Mycobacterium tuberculosis Beijing B0/W148 cluster. Researchers made corrections to earlier findings and emphasized the importance of understanding this bacteria's behavior in spreading the disease. This knowledge can help improve treatment strategies for tuberculosis, which remains a significant health issue worldwide. Who this helps: This helps patients with tuberculosis and healthcare providers working to treat the disease.

Plain English
This study looked at a type of tuberculosis (TB) called multidrug-resistant (MDR) TB, specifically focusing on a strain known as the Beijing genotype in Portugal and Guinea-Bissau. Researchers found that two specific clusters of this strain, known as GC1 and GC2, were present, indicating that these countries are seeing a rise in MDR-TB cases linked to this strain. This matters because it highlights how MDR-TB can spread across borders and evolve, posing a greater challenge to public health efforts. Who this helps: This benefits public health officials, researchers, and healthcare providers tackling TB in affected regions.

Plain English
This study examined tuberculosis bacteria in Novouralsk, a closed city in Russia, where many people are both infected with HIV and have a history of imprisonment. Researchers found that 78.9% of the bacteria belonged to a specific strain that is commonly resistant to multiple drugs, with an alarming 92.1% of this strain being multidrug-resistant. This is concerning because it indicates that current measures to control the spread of tuberculosis in this area are not working effectively. Who this helps: This helps patients, particularly those with HIV and a history of imprisonment, who are at higher risk for drug-resistant tuberculosis.

Plain English
This study examined drug-resistant strains of tuberculosis (TB) in Russia, particularly focusing on a specific lineage called the Beijing genotype. Researchers analyzed 184 genomes and discovered that all Russian strains were resistant to multiple TB drugs, with a significant number showing high-level resistance known as extensive drug resistance (XDR). They identified six key mutations contributing to this resistance, affecting treatment options for patients, and traced the origin of these strains back to the early 1970s. Who this helps: This helps patients with drug-resistant TB and healthcare providers involved in their treatment.

Plain English
This study examined the genetic differences in BCG vaccine strains used in Russia and how these variations relate to health issues in children who experienced adverse reactions after vaccination. Researchers found 15 specific genetic changes in the strains, particularly in seed lots 361, 367, and 368, some of which were linked to immune responses in children. Understanding these genetic differences is crucial because it can help improve the effectiveness and safety of the BCG vaccine in preventing tuberculosis. Who this helps: This benefits patients, especially children receiving the BCG vaccine, and healthcare providers involved in vaccination programs.

Plain English
This study looked at how genetic differences in tuberculosis bacteria might make them resistant to a new drug called Perchlozone (PCZ), which is used to treat multidrug-resistant tuberculosis (MDR-TB). Researchers analyzed the genetic material of bacteria from nine patients who were treated with PCZ and found that most had specific mutations that likely contributed to resistance; seven out of the nine patients shared a common mutation, while a different mutation appeared in one patient after several months of treatment. Understanding these genetic factors is important because they can help doctors make better treatment choices for patients with MDR-TB. Who this helps: This helps patients with multidrug-resistant tuberculosis and their doctors.

Plain English
This study looked at a strain of tuberculosis (TB) in northern Russia, particularly in the Komi Republic, where there's a high rate of drug-resistant TB (26%). Researchers found that the Beijing B0/W148 strain was prevalent, accounting for 56.2% of samples, and among them, 83.3% were multidrug-resistant. The higher presence of this strain in cities linked to Gulag camps suggests it spreads more easily compared to other strains, which is significant for controlling TB in the region. Who this helps: This information benefits public health officials and doctors working to manage and treat tuberculosis.

Plain English
This study examined a specific strain of tuberculosis called Beijing B0/W148, which is prevalent in Russia and some former Soviet countries. Researchers analyzed the genetic makeup and protein behavior of this strain, finding that a gene called whiB6 was much more active in this strain, showing an increase of nearly 40 times compared to others. They also identified 5 new genes and corrected the starting points for 10 genes based on their findings. Understanding these features is important because it can lead to better treatments and ways to combat this particular strain of tuberculosis. Who this helps: This research benefits patients with tuberculosis, doctors treating these patients, and public health officials.